Michelle LaSpaluto
Director of Finance/CFO at CHIMERIX, INC.
Net worth: 98 900 $ as of 2024-04-29
Profile
Michelle LaSpaluto is currently the Chief Financial Officer at Chimerix, Inc. since 2023.
Previously, she worked as the Senior Director-Accounting at AlphaVax, Inc. from 2000 to 2011.
Ms. LaSpaluto completed her undergraduate degree at Michigan State University and holds an MBA from East Carolina University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CHIMERIX, INC.
0.12% | 2024-02-13 | 110,999 ( 0.12% ) | 98 900 $ | 2024-04-29 |
Michelle LaSpaluto active positions
| Companies | Position | Start |
|---|---|---|
| CHIMERIX, INC. | Director of Finance/CFO | 2023-11-30 |
Former positions of Michelle LaSpaluto
| Companies | Position | End |
|---|---|---|
AlphaVax, Inc.
 AlphaVax, Inc. Pharmaceuticals: MajorHealth Technology AlphaVax, Inc. involves in clinical-stage biopharmaceutical company. It develops vaccine technology bio products. The firm products include Alphavax and pipleline bio products. It focuses on commercial potential of its alphavaccine vector technology in cancer immunotherapy. The company was founded in 1997 and is headquartered in Durham, NC. | Comptroller/Controller/Auditor | 2011-05-31 |
Training of Michelle LaSpaluto
| East Carolina University | Masters Business Admin |
| Michigan State University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CHIMERIX, INC. | Health Technology |
| Private companies | 1 |
|---|---|
AlphaVax, Inc.
AlphaVax, Inc. Pharmaceuticals: MajorHealth Technology AlphaVax, Inc. involves in clinical-stage biopharmaceutical company. It develops vaccine technology bio products. The firm products include Alphavax and pipleline bio products. It focuses on commercial potential of its alphavaccine vector technology in cancer immunotherapy. The company was founded in 1997 and is headquartered in Durham, NC. | Health Technology |
- Stock Market
- Insiders
- Michelle LaSpaluto